Literature DB >> 11740479

The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.

A R Tappuni1, G J Fleming.   

Abstract

OBJECTIVE: The purpose of this study was to compare the prevalence of oral manifestations in human immunodeficiency virus (HIV)-infected patients on monotherapy, dual therapy, or triple therapy with the prevalence of those not on antiretroviral therapy (ART). STUDY
DESIGN: A cross-sectional study of the oral manifestations of HIV was carried out on 284 HIV-infected patients, 89 of whom were undergoing ART (12 on monotherapy, 41 on dual therapy, and 36 on triple therapy) and 195 who were not undergoing ART. Oral manifestations were recorded by using established presumptive clinical criteria. Chi-square statistical tests and separate bivariate analyses were conducted by using the Spearman rank correlation to describe the relationship between the prevalence of oral lesions and ART.
RESULTS: The detection of oral manifestations was significantly decreased in subjects on dual therapy and subjects on triple therapy in comparison with patients on monotherapy (P <.05) and those on no ART regimen (P =.014). Oral manifestations were also significantly increased, with CD4 counts <200 cells/mm(3) and a viral load >3000 copies/mL (P <.001).
CONCLUSIONS: Compared with the non-ART group, subjects on combination ART had significantly fewer HIV-related oral manifestations-probably as a result of an expression of their reconstituted immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740479     DOI: 10.1067/moe.2001.118902

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  31 in total

1.  Detection of the Epstein-Barr virus (EBV) by in situ hybridization as definitive diagnosis of hairy leukoplakia.

Authors:  Paulo Henrique Braz-Silva; Nathalie Pepe Medeiros de Rezende; Karem Lopez Ortega; Raimunda Telma de Macedo Santos; Marina Helena Cury Gallottini de Magalhães
Journal:  Head Neck Pathol       Date:  2008-02-08

2.  Orofacial manifestations in HIV positive children attending Mildmay Clinic in Uganda.

Authors:  Juliet Nabbanja; Sheba Gitta; Stefan Peterson; Charles Mugisha Rwenyonyi
Journal:  Odontology       Date:  2012-02-24       Impact factor: 2.634

3.  The association between oral disease and type of antiretroviral therapy among perinatally HIV-infected youth.

Authors:  Caroline H Shiboski; Tzy-Jyun Yao; Jonathan S Russell; Mark I Ryder; Russell B Van Dyke; George R Seage; Anna-Barbara Moscicki
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

4.  Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.

Authors:  L T Vernon; Plp Jayashantha; M M Chidzonga; M C Komesu; R G Nair; N W Johnson
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

Review 5.  Overview of the oral HIV/AIDS Research Alliance Program.

Authors:  C H Shiboski; J Y Webster-Cyriaque; M Ghannoum; J S Greenspan; D Dittmer
Journal:  Adv Dent Res       Date:  2011-04

Review 6.  Current trends and new developments in HIV research and periodontal diseases.

Authors:  Mark I Ryder; Caroline Shiboski; Tzy-Jyun Yao; Anna-Barbara Moscicki
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

7.  Effects of long-term use of HAART on oral health status of HIV-infected subjects.

Authors:  Wipawee Nittayananta; Sineepat Talungchit; Sutep Jaruratanasirikul; Kachornsakdi Silpapojakul; Panthip Chayakul; Ampaipith Nilmanat; Nannapat Pruphetkaew
Journal:  J Oral Pathol Med       Date:  2010-02-22       Impact factor: 4.253

8.  Increasing access to oral health care for people living with HIV/AIDS in the U.S.: baseline evaluation results of the Innovations in Oral Health Care Initiative.

Authors:  Jane E Fox; Carol R Tobias; Sara S Bachman; David A Reznik; Serena Rajabiun; Niko Verdecias
Journal:  Public Health Rep       Date:  2012-05       Impact factor: 2.792

9.  Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.

Authors:  Luciana Pomarico; Daniella Ferraz Cerqueira; Rosangela Maria de Araujo Soares; Ivete Pomarico Ribeiro de Souza; Gloria Fernanda Barbosa de Araujo Castro; Sigmund Socransky; Anne Haffajee; Ricardo Palmier Teles
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-08

Review 10.  Oral complications of HIV disease.

Authors:  Jair C Leao; Camila M B Ribeiro; Alessandra A T Carvalho; Cristina Frezzini; Stephen Porter
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.